drugset / Trial / NCT00576251
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to describe the differences in efficacy between TOBRADEX Ophthalmic Suspension and Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension in the treatment of ocular inflammation and infection associated with blepharaconjunctivitis
Timeline
- Start
- 2007-10
- Primary completion
- 2008-02
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Dexamethasone | Small molecule | 0.05 % | Other |
| Background | Tobramycin | Small molecule | 0.3 % | Other |